EGFR and colorectal cancer: However, CD9, another canonical EV marker protein, is associated with EGFR-positive EVs; most CD9-positive EVs are EGFR-positive in colorectal cancer cell DiFi (42), and approximately 74% of EGFR-positive EVs are CD9-positive in glioma cancer cell U373vIII (55).